Vyne Therapeutics
Price & Volume
Stats
See more52W Range | $1.57-$3.61 |
Market Cap | $44.2M |
Shares Short | 62,376 |
Financials
See moreRevenue (12 Mos) | $486,000 |
Revenue Growth (YoY) | 46.7% |
Gross Profit (12 Mos) | $477,000 |
Diluted EPS | $1.72 |
News
See moreYahoo Finance • last year
VYNE Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Yahoo Finance • last year
VYNE Therapeutics to Host Virtual R&D Day Event on November 9, 2023
Yahoo Finance • last year
VYNE Therapeutics Announces Closing of Previously Announced Private Placement of $88.2 Million
About
CEO | Mr. David T. Domzalski |
CFO | Mr. Tyler Zeronda CPA |
Address | 685 Route 202/206 N, Bridgewater, NJ, United States, 08807 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 10 |
